Moderna COVID-19 Booster: Effective Protection Against New Variants, Early Clinical Trial Shows

Medicine & Technology May 06, 2021

An early clinical trial recently showed that the new Moderna COVID-19 booster could be an effective shield against the variants of coronavirus originally found in South Africa and Brazil.

Pfizer Seeks FDA’s Approval for Younger Population’s Vaccination Aged 12 to 15 Year Olds

Apr 09, 2021

Pfizer has asked the FDA for an amendment to its emergency use authorization for its COVID-19 vaccine to expand its use in individuals aged 12 to 15 in the United States.

Adolescents Show High Tolerance on Pfizer-BioNTech COVID-19 Vaccine, 100-Percent Efficacy

Mar 31, 2021

Pfizer announced that the Pfizer-BioNTech COVID-19 vaccine showed a 100-percent efficacy and is well-tolerated in younger people whose ages range between 12 and 15 years.

Pfizer-BioNtech COVID-19 Vaccine Can Now Be Stored at Higher Temperatures

Mar 26, 2021

The Pfizer-BioNTech COVID-19 vaccine just got the EU regulator's approval to be stored at a new higher temperature. This is part of their initiative to help in the rapid rollout of vaccines.

Pfizer-BioNTech Launch Trials to Test COVID-19 Vaccine on Kids as Young as Six Months

Mar 25, 2021

The first young children in the pediatric trial of the Pfizer-BioNTech COVID-19 vaccine have already been given their initial jabs.